Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistanceJulia M W Gee, Robert I Nicholson, Denise Barrow, et al.
Breast Cancer Research and Treatment|January 31, 2012
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II studyIrene Kuter, Julia M W Gee, Roberto Hegg, et al.
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Breast Cancer Research and Treatment|February 25, 2009
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHany Onsy Habashy, Desmond G Powe, Cindy M Staka, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
Endocrine-Related Cancer|August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatmentJ M W Gee, A Howell, W J Gullick, et al.
Human Molecular Genetics|July 6, 2016
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancerMichael J G Milevskiy, Fares Al-Ejeh, Jodi M Saunus, et al.
Nature Communications|January 18, 2020
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancerJoanna Achinger-Kawecka, Fatima Valdes-Mora, Phuc-Loi Luu, et al.
The FEBS Journal|July 24, 2013
Global characterization of signalling networks associated with tamoxifen resistance in breast cancerBrigid C Browne, Falko Hochgräfe, Jianmin Wu, et al.
Pageof 7